FierceBiotech

AMRI RECEIVES NIH CONTRACT AWARD FOR THE FORMULATION DEVELOPMENT AND MANUFACTURE OF PRE-CLINICAL AND CLINICAL DRUG PRODUCT

ALBANY, N.Y., Jan. 19, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...
Research Snipers

Standardised Biological Simulants: The Role of Synthetic Urine in Medical Testing and Device Validation

Synthetic urine is engineered to replicate the essential physical and chemical properties of real urine rather than its ...
Business Wire

ReForm Biologics Announces An Evaluation Agreement for Enhancing Formulation of Two Clinical-stage Pipeline Programs

WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a new ...
Lexington Herald Leader

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (”GMP”) Clinical Batch of ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent pending drug delivery ...
FierceBiotech

NextPharma's Sterile Product Development Center in Belgium has Formulated Viscous, Lipid Based Formulation for Clinical Trials

NextPharma Technologies Announces that its Sterile Product Development Center in Belgium has been Successful in Formulating, Manufacturing and Labeling a Viscous, Lipid Based Formulation for Clinical ...
FiercePharma

Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today announced that it has appointed Albany Molecular ...